Definitive evidence of the prognostic influence of the <i>ETV6-ABL1</i> fusion in haematological neoplasms is lacking; however, overall data suggest that it is a poor prognostic factor, particularly in patients with ALL and AML. Here, ABL1 is linked to acute myeloid leukemia.